iNtRON Biotechnology, Inc. (048530.KQ)

KRW 5500.0

(-4.35%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 98.61 Billion 140.95 Billion 153.36 Billion 100.53 Billion 89.03 Billion 54.79 Billion
Total Current Assets 60.97 Billion 113.92 Billion 125.51 Billion 81.32 Billion 75.28 Billion 40.15 Billion
Cash And Short Term Investments 57.13 Billion 108.22 Billion 113.49 Billion 66.16 Billion 69.56 Billion 33.1 Billion
Cash and Cash Equivalents 40.98 Billion 25.81 Billion 75.17 Billion 59.92 Billion 53.32 Billion 21.12 Billion
Short Term Investments 16.14 Billion 82.4 Billion 38.32 Billion 6.24 Billion 16.23 Billion 11.98 Billion
Net Receivables 2.69 Billion 4.39 Billion 10.64 Billion 12.2 Billion 2.96 Billion 5.05 Billion
Inventory 1.01 Billion 800.39 Million 1 Billion 1.53 Billion 1.34 Billion 1.46 Billion
Other Current Assets 140.77 Million 508.66 Million 372.72 Million 1.41 Billion 1.4 Billion 532.61 Million
Total Non-Current Assets 37.63 Billion 27.03 Billion 27.85 Billion 19.2 Billion 13.74 Billion 14.64 Billion
Net PPE 22.69 Billion 15.03 Billion 13.75 Billion 11.95 Billion 7.55 Billion 7.58 Billion
Good Will And Intangible Assets 1.4 Billion 1.38 Billion 1.21 Billion 1.13 Billion 1.18 Billion 951.54 Million
Good Will - - - - - -
Intangible Assets 1.4 Billion 1.38 Billion 1.21 Billion 1.13 Billion 1.18 Billion 951.54 Million
Long-Term Investments 13.01 Billion 9.77 Billion 10.87 Billion 4.44 Billion 1.48 Billion 1.52 Billion
Tax Assets 5.00 7.00 1.15 Billion 830.02 Million 2.55 Billion 3.81 Billion
Other Non Current Assets 516.77 Million 836.12 Million 850.46 Million 844.55 Million 971.15 Million 758.29 Million
Other Assets 1.00 - 1.00 1.00 - -
Total Liabilities 1.88 Billion 34.77 Billion 52.01 Billion 15.15 Billion 24.01 Billion 15.65 Billion
Total Current Liabilities 785.96 Million 32.21 Billion 33.25 Billion 12.7 Billion 4.67 Billion 14.16 Billion
Account Payables 418 Thousand 97 Million 561.02 Million 206.66 Million 263.6 Million 161.45 Million
Tax Payables - - 1.26 Billion 352.73 Million - -
Short Term Debt 144.61 Million 30.98 Billion 29.62 Billion 10.29 Billion 977.61 Million 3.9 Billion
Deferred Revenue 141.64 Million 421.51 Million 332.77 Million 613.11 Million 2.6 Billion 657.29 Million
Other Current Liabilities 499.28 Million 713.99 Million 2.73 Billion 1.58 Billion 827.81 Million 9.44 Billion
Total Non Current Liabilities 1.09 Billion 2.55 Billion 18.76 Billion 2.45 Billion 19.33 Billion 1.48 Billion
Long-Term Debt 258.29 Million 286.37 Million 16.06 Billion 174.27 Million 18.51 Billion 224.99 Million
Deferred Revenue Non Current 41.65 Million 41.65 Million 1.85 Billion 1.86 Billion - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 710.45 Million 666.88 Million 783.73 Million 412.5 Million 825.67 Million 1.25 Billion
Other Liabilities - - - - - -
Total Equity 96.73 Billion 106.18 Billion 101.34 Billion 85.37 Billion 65.01 Billion 39.14 Billion
Stock Holders Equity 96.73 Billion 106.18 Billion 101.34 Billion 85.37 Billion 64.96 Billion 39.09 Billion
Common Stock 17.07 Billion 17.07 Billion 16.89 Billion 16.57 Billion 15.98 Billion 7.72 Billion
Retained Earnings 48.67 Billion 18.54 Billion 12.72 Billion 3.08 Billion -11.68 Billion -8.65 Billion
Accumulated other comprehensive income 967.75 Million 545.38 Million 463.27 Million 1.98 Billion 15.5 Billion -47.8 Million
Common Stock Equity 96.73 Billion 106.18 Billion 101.34 Billion 85.37 Billion 64.96 Billion 39.09 Billion
Capital Lease Obligation 258.29 Million 286.37 Million 61.61 Million 174.27 Million 306.35 Million -
Total Investments 29.16 Billion 92.18 Billion 49.2 Billion 10.69 Billion 17.72 Billion 13.5 Billion
Total Debt 402.9 Million 31.27 Billion 45.75 Billion 10.47 Billion 19.79 Billion 4.13 Billion
Net Debt -40.58 Billion 5.46 Billion -29.41 Billion -49.45 Billion -33.53 Billion -16.99 Billion

Balance Sheet Charts